Skip to main content

Mayo Clinic has joined with two industry partners to start an accelerator for cell- and gene-therapy startups, part of an effort the healthcare provider is making to expand in this emerging field of biotechnology.

Mayflower BioVentures, the accelerator, will launch companies to advance potential cell and gene therapies discovered at Mayo Clinic. Innoforce Pharmaceuticals Inc., a provider of biotech contract development and manufacturing services, and Hibiscus BioVentures, a firm that builds and invests in biotech startups,…

Full Article: